Lung cancer The diagnosis and treatment of lung cancer

Lung cancer
The diagnosis and treatment of lung cancer
Issued: April 2011
NICE clinical guideline 121
guidance.nice.org.uk/cg121

NICE has accredited the process used by the Centre for Clinical Practice at NICE to produce
guidelines. Accreditation is valid for 5 years from September 2009 and applies to guidelines produced
since April 2007 using the processes described in NICE's 'The guidelines manual' (2007, updated
2009). More information on accreditation can be viewed at www.nice.org.uk/accreditation
© NICE 2011

Lung cancer

NICE clinical guideline 121

Contents
Introduction .................................................................................................................................. 4
Patient-centred care ..................................................................................................................... 6
Key priorities for implementation .................................................................................................. 7
1 Guidance ................................................................................................................................... 9
1.1 Access to services and referral ......................................................................................................... 9
1.2 Communication ................................................................................................................................. 11
1.3 Diagnosis and staging ....................................................................................................................... 12
1.4 Treatment ......................................................................................................................................... 17
1.5 Palliative interventions and supportive and palliative care ................................................................ 25
1.6 Follow-up and patient perspectives................................................................................................... 27

2 Notes on the scope of the guidance